Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
Suhail
S M
SM
Department of Renal Medicine, Singapore.
Vathsala
A
A
Lou
H X
HX
Woo
K T
KT
D044466:Asian People; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D007970:Leukopenia / Q000139:chemically induced; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012846:Singapore
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid; D001379:Azathioprine; D008775:Methylprednisolone